市場調査レポート

商品コード

DTC臨床検査の世界市場：用途別（遺伝子検査、糖尿病、COVID、STD、定期、CBC）、試料タイプ別（唾液、尿、血液）- 2030年までの予測

Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood)-Global Forecast to 2030

出版日: 2023年05月17日
発行: Meticulous Research
ページ情報: 英文 209 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,175 612,973円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,875 862,567円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global Site License)

USD 7,875 1,156,207円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のDTC臨床検査の市場規模は、2023年～2030年にかけて、CAGRで10.9%で拡大し、2030年までに79億2,000万米ドルに達すると予測されています。

当レポートでは、世界のDTC臨床検査市場について調査し、市場の現状とともに、用途別、試料タイプ別動向、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1 Europe: Some of the Countries Requiring Medical Supervision for Genetic Testing
Table 2 Price Comparison: DTC Laboratory Tests Vs. Conventional Laboratory Tests (USD)
Table 3 DTC Genetic Testing: Pricing Analysis
Table 4 Global Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 5 Difference Between Conventional Genetic Testing and DTC Genetic Testing
Table 6 Global Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 7 Global Direct-to-consumer Genetic Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 8 Global DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021-2030 (USD Million)
Table 9 Global DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021-2030 (USD Million)
Table 10 Global DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021-2030 (USD Million)
Table 11 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 12 Global Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021-2030 (USD Million)
Table 13 Global Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021-2030 (USD Million)
Table 14 Burden of Neurological Conditions (DALYs Per 100,000 Population)
Table 15 Global Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021-2030 (USD Million)
Table 16 Incidence of Common Genetic Disorders
Table 17 Global Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021-2030 (USD Million)
Table 18 Global DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021-2030 (USD Million)
Table 19 Global DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021-2030 (USD Million)
Table 20 Number of People with Diabetes, by Region (2021 Vs. 2030) (In Thousands)
Table 21 Global DTC Diabetes Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 22 Commonly Performed Routine Clinical Testing
Table 23 Global DTC Routine Clinical Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 24 Commonly Tests Included in a Thyroid Panel
Table 25 Global DTC Thyroid Function Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 26 COVID-19 Cases & Deaths, by Region (As of 12th March 2023)
Table 27 Global Direct-to-consumer Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021-2030 (USD Million)
Table 28 HIV Statistics (2021)
Table 29 Global Direct-to-consumer Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021-2030 (USD Million)
Table 30 Commonly Performed DTC Tests for Other Applications
Table 31 Global Direct-to-consumer Laboratory Testing Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
Table 32 Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 33 Global Direct-to-consumer Laboratory Testing Market for Blood, by Country/Region, 2021-2030 (USD Million)
Table 34 Global Direct-to-consumer Laboratory Testing Market for Saliva, by Country/Region, 2021-2030 (USD Million)
Table 35 Reason for Conducting a Urine Test
Table 36 Global Direct-to-consumer Laboratory Testing Market for Urine, by Country/Region, 2021-2030 (USD Million)
Table 37 Sample Type for Various Test
Table 38 Global Direct-to-consumer Laboratory Testing Market for Other Samples, by Country/Region, 2021-2030 (USD Million)
Table 39 Global Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 40 North America: Direct-to-consumer Laboratory Testing Market, by Country, 2021-2030 (USD Million)
Table 41 North America: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 42 North America: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 43 North America: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 44 North America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 45 Price Comparison of Traditional Laboratory Testing Vs. DTC Laboratory Testing in the U.S.
Table 46 U.S.: Key Macro & Micro Indicators
Table 47 U.S.: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 48 U.S.: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 49 U.S.: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 50 U.S.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 51 Canada: Key Macro Indicators
Table 52 Canada: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 53 Canada: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 54 Canada: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 55 Canada: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 56 Europe: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 57 Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 58 Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 59 Europe: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 60 Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 61 U.K.: Prevalence of Various Chronic Conditions
Table 62 U.K.: Key Macro Indicators
Table 63 U.K.: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 64 U.K.: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 65 U.K.: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 66 U.K.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 67 Germany: Key Macro Indicators
Table 68 Germany: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 69 Germany: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 70 Germany: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 71 Germany: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 72 Italy: Key Macro Indicators
Table 73 Italy: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 74 Italy: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 75 Italy: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 76 Italy: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 77 France: Key Macro Indicators
Table 78 France: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 79 France: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 80 France: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 81 France: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 82 Spain: Key Macro Indicators
Table 83 Spain: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 84 Spain: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 85 Spain: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 86 Spain: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 87 Rest of Europe: Percent of Elderly Population (2012 Vs. 2021 Vs. 2022)
Table 88 Rest of Europe: Cancer Statistics (2020 Vs. 2030)
Table 89 Rest of Europe: Diabetes Statistics (2021 Vs. 2030) (In Thousands)
Table 90 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 91 Rest of Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 92 Rest of Europe: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 93 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 94 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021-2030 (USD Million)
Table 95 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 96 Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 97 Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 98 Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 99 China: Some of the Direct-to-consumer Genetic Testing Products Comparison
Table 100 China: Key Macro Indicators
Table 101 China: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 102 China: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 103 China: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 104 China: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 105 Japan: Key Macro Indicators
Table 106 Japan: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 107 Japan: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 108 Japan: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 109 Japan: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 110 India: Key Trends in the Direct-to-consumer Laboratory Testing Market
Table 111 India: Key Macro Indicators
Table 112 India: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 113 India: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 114 India: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 115 India: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 116 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 117 Rest of Asia-Pacific: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 118 Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 119 Rest of Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 120 Rest of Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 121 Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 122 Latin America: Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 123 Latin America: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 124 Latin America: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 125 Latin America: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 126 Latin America: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 127 Latin America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 128 Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Application, 2021-2030 (USD Million)
Table 129 Middle East & Africa: Direct-to-consumer Genetic Testing Market, by Type, 2021-2030 (USD Million)
Table 130 Middle East & Africa: Diseases Risk Assessment Market, by Type, 2021-2030 (USD Million)
Table 131 Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021-2030 (USD Million)
Table 132 Recent Developments, by Company, 2020-2023

List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Direct-to-consumer Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8 Global Direct-to-consumer Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9 Direct-to-consumer Laboratory Testing Market Size, by Geography
Figure 10 U.S.: Regulations for DTC Laboratory Testing
Figure 11 Types of Direct-to-consumer Tests and Their Regulatory Pathways
Figure 12 Genome Sequencing Costs, 2010-2021 (USD)
Figure 13 Global Direct-to-consumer Laboratory Testing Market, by Application, 2023-2030 (USD Million)
Figure 14 Process of DTC Genetic Testing
Figure 15 Estimated Number of New Cancer Cases (2020-2040)
Figure 16 Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 17 Benefits of Saliva Sampling
Figure 18 Global Direct-to-consumer Laboratory Testing Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 19 North America: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 20 U.S.: Disposable Personal Income (USD Billion)
Figure 21 Europe: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 22 U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population
Figure 23 Italy: Percentage of Population Aged 65 & Above
Figure 24 Spain: Number of People Living with HIV (2010-2021)
Figure 25 Asia-Pacific: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 26 Japan: Percentage of Population Aged 65 and Above (2010-2030)
Figure 27 Brazil: Number of People with Diabetes (In Thousands)
Figure 28 Argentina: HIV Statistics
Figure 29 Key Growth Strategies Adopted by Leading Players, 2020-2023
Figure 30 Competitive Dashboard: Direct-to-consumer Laboratory Testing Market
Figure 31 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 32 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 33 Global Direct-to-consumer Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 34 Quest Diagnostics Incorporated.: Financial Overview (2022)
Figure 35 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 36 23andMe Holding Co.: Financial Overview (2021)
Figure 37 Myraid Genetics, Inc: Financial Overview (2022)
Figure 38 Thorne Healthtech, Inc.: Financial Overview (2022)

Product Code: MRHC - 104667

The global DTC laboratory testing market is projected to reach $7.92 billion by 2030, at a CAGR of 10.9% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the increased consumer awareness regarding personal health management. Consumers can order a DTC lab test directly without consulting their healthcare provider and get results, allowing them to monitor & manage their health & wellness.

Furthermore, the growing adoption of telehealth, the rising popularity of DTC laboratory testing in emerging economies, and the increasing penetration of DTC pharmacogenomic testing provide a significant growth opportunity for this market. However, sample integrity and interference issues, regulatory concerns, the lack of reimbursements, and the lack of extensive test portfolios compared to conventional laboratory testing may restrain the growth of this market. Additionally, the concerns regarding the security and privacy of genomic data, misinterpretation of test results, and the lack of professional medical counseling pose a major challenge for the players operating in this market.

Based on application, in 2023, the genetic testing segment is expected to account for the largest share of the DTC laboratory testing market. The genetic testing segment is further segmented into ancestry/genealogy, disease risk assessment, carrier status, and other genetic tests. In 2023, the ancestry/genealogy segment is expected to account for the largest share of the global direct-to-consumer genetic testing market. Factors such as increased consumer interest & curiosity regarding ancestry, technological advancements to make genetic testing accessible, strong advertising & marketing by the companies, high racial diversity and interracial mix in some countries, and the advantages such as convenience & accessibility are driving the growth of this segment.

Based on sample type, in 2023, the blood segment is expected to account for the largest share of the DTC laboratory testing market. The large market share of this segment is attributed to the demand for tests that require blood samples and the advantages of blood samples in obtaining reliable results in a wide range of test portfolios.

An in-depth analysis of the geographical scenario of the global DTC laboratory testing market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the global DTC laboratory testing market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global DTC laboratory testing market.

The key players operating in the global DTC laboratory testing market are Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), 23andMe Holding Co. (U.S.), Myriad Genetics, Inc. (U.S.), Everlywell, Inc. (U.S.), DirectLabs, LLC. (U.S.), Ancestry.com, LLC (U.S.), MyMedLab, Inc. (U.S.), ANY LAB TEST NOW (U.S.), Thorne HealthTech, Inc. (U.S.), and LetsGetChecked, Inc. (U.S.).

Other than these, there are several regional players such as Color Health, Inc. (U.S), Laboratoire CERBA (France), MyHeritage Ltd. (Israel), Genova Diagnostics Inc. (U.S.), Gene by Gene, Ltd. (U.S.), Metropolis Healthcare Limited (India), Vitagene (U.S.), SRL Limited (India), Hirotsu Bio Science (Japan), Ambry Genetics Corporation (U.S.), Mapmygenome India Limited (India), FamilyTreeDNA (U.S.), Genera (Brazil), Veritas Intercontinental (Spain), Medichecks.com Ltd. (U.K.), EasyDNA (U.S.) (Subsidiary of Genetic Technologies Limited (Australia), Cerascreen Biotech LLC (U.K.), and Living DNA Ltd (U.K.).

Scope of the Report:

DTC Laboratory Testing Market, by Application

Genetic Testing
- Ancestry/Genealogy
- Disease Risk Assessment
Cancer
Cardiovascular Diseases
Neurological Diseases
Other Diseases

(Note: Disease risk assessment testing for other diseases includes celiac disease, alpha-1 antitrypsin deficiency, factor XI deficiency, glucose-6-phosphate dehydrogenase deficiency, etc.)

Carrier Status
Other Genetic Tests

(Note: The other genetic tests majorly include direct-to-consumer genetic testing for pharmacogenomics, skin care DNA tests, and nutrigenomic testing)

Routine Clinical Testing
Diabetes Testing
COVID-19
Sexually Transmitted Disease Testing
Thyroid Function Testing
Other Applications

(Note: The other applications segment comprises drug screening, infectious disease testing (Tuberculosis, Chicken Pox, Measles, Mumps, Rubella, UTI), allergy testing, fertility, pregnancy and nutritional testing)

DTC Laboratory Testing Market, by Sample Type

Blood
Saliva
Urine
Other Sample Types

(Note: The other sample types segment comprises stool, nasopharyngeal swab, vaginal swab, buccal swab, and semen)

DTC Laboratory Testing Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

1. Market Definition & Scope

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
- 4.2.1. Impact Analysis of Market Dynamics
4.3. Direct-to-consumer Laboratory Testing Market: Regulatory Analysis
- 4.3.1. Overview
- 4.3.2. North America
  - 4.3.2.1. U.S.
  - 4.3.2.2. Canada
- 4.3.3. Europe
- 4.3.4. Asia-Pacific
  - 4.3.4.1. China
  - 4.3.4.2. Japan
  - 4.3.4.3. India
- 4.3.5. Latin America
- 4.3.6. Middle East
4.4. Direct-to-consumer Laboratory Testing Market: Pricing Analysis
4.5. Case Studies
- 4.5.1. DTC Genetic Testing Companies Adapting to the Industry Slowdown
4.6. Industry Trends
- 4.6.1. Declining Costs of Sequencing to Make DTC Genetic Testing More Accessible
- 4.6.2. Shift from Physician-driven to Consumer-driven Healthcare

5. Direct-to-consumer Laboratory Testing Market Assessment-by Application

5.1. Overview
5.2. Genetic Testing
- 5.2.1. Ancestry/Genealogy
- 5.2.2. Disease Risk Assessment
  - 5.2.2.1. Cancer
  - 5.2.2.2. Cardiovascular Diseases
  - 5.2.2.3. Neurological Diseases
  - 5.2.2.4. Other Diseases
- 5.2.3. Carrier Status
- 5.2.4. Other Genetic Tests
5.3. Diabetes Testing
5.4. Routine Clinical Testing
5.5. Thyroid Function Testing
5.6. COVID-19 Testing
5.7. Sexually Transmitted Disease Testing
5.8. Other Applications

6. Direct-to-consumer Laboratory Testing Market Assessment-by Sample Type

6.1. Overview
6.2. Blood
6.3. Saliva
6.4. Urine
6.5. Other Samples

7. Direct-to-consumer Laboratory Testing Market Assessment-by Geography

7.1. Overview
7.2. North America
- 7.2.1. U.S.
- 7.2.2. Canada
7.3. Europe
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. Italy
- 7.3.4. France
- 7.3.5. Spain
- 7.3.6. Rest of Europe (RoE)
7.4. Asia-Pacific
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. India
- 7.4.4. Rest of Asia-Pacific (RoAPAC)
7.5. Latin America
7.6. Middle East & Africa

8. Competition Analysis

8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Dashboard
- 8.3.1. Industry Leaders
- 8.3.2. Market Differentiators
- 8.3.3. Vanguards
- 8.3.4. Emerging Companies
8.4. Vendor Benchmarking
8.5. Market Share Analysis (2022)
- 8.5.1. Ancestry.com, LLC (U.S.)
- 8.5.2. Laboratory Corporation of America Holdings (U.S.)
- 8.5.3. 23andMe Holding Co. (U.S.)
- 8.5.4. Quest Diagnostics Incorporated (U.S.)

9. Company Profiles

9.1. Quest Diagnostics Incorporated
9.2. Laboratory Corporation of America Holdings
9.3. 23andMe Holding Co.
9.4. Myriad Genetics, Inc.
9.5. Everlywell, Inc. (A Subsidiary of Everly Health, Inc.)
9.6. DirectLabs, LLC
9.7. Ancestry.com, LLC
9.8. MyMedLab, Inc.
9.9. ANY LAB TEST NOW
9.10. Thorne Healthtech, Inc.
9.11. LetsGetChecked, Inc.
9.12. Other Companies

10. Appendix

10.1. Available Customization
10.2. Related Reports

DTC臨床検査の世界市場：用途別（遺伝子検査、糖尿病、COVID、STD、定期、CBC）、試料タイプ別（唾液、尿、血液）- 2030年までの予測

Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood)-Global Forecast to 2030

目次

第1章市場の定義と範囲

第2章調査手法

第3章エグゼクティブサマリー

第4章市場洞察

第5章 DTC臨床検査市場の評価、用途別

第6章 DTC臨床検査市場の評価、試料タイプ別

第7章 DTC臨床検査市場の評価、地域別

第8章競合分析

第9章企業プロファイル

第10章付録

List of Tables

List of Figures

Scope of the Report:

TABLE OF CONTENTS

1. Market Definition & Scope

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Direct-to-consumer Laboratory Testing Market Assessment-by Application

6. Direct-to-consumer Laboratory Testing Market Assessment-by Sample Type

7. Direct-to-consumer Laboratory Testing Market Assessment-by Geography

8. Competition Analysis

9. Company Profiles

10. Appendix

DTC臨床検査の世界市場：用途別（遺伝子検査、糖尿病、COVID、STD、定期、CBC）、試料タイプ別（唾液、尿、血液）- 2030年までの予測

Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood)-Global Forecast to 2030

目次

第1章 市場の定義と範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

第5章 DTC臨床検査市場の評価、用途別

第6章 DTC臨床検査市場の評価、試料タイプ別

第7章 DTC臨床検査市場の評価、地域別

第8章 競合分析

第9章 企業プロファイル

第10章 付録

List of Tables

List of Figures

Scope of the Report:

TABLE OF CONTENTS

1. Market Definition & Scope

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Direct-to-consumer Laboratory Testing Market Assessment-by Application

6. Direct-to-consumer Laboratory Testing Market Assessment-by Sample Type

7. Direct-to-consumer Laboratory Testing Market Assessment-by Geography

8. Competition Analysis

9. Company Profiles

10. Appendix

第1章市場の定義と範囲

第2章調査手法

第3章エグゼクティブサマリー

第4章市場洞察

第8章競合分析

第9章企業プロファイル

第10章付録